Condom makers jockey for position in barrier warfare. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Condom makers jockey for position in barrier warfare. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

AIDS Alert. 1995 Jan;10(1):6-7. Unique Identifier : AIDSLINE AIDS/95700023


Abstract: U.S. condom manufacturers are receiving competition from high quality Japanese products. However, the sale of a plastic polyurethane condom by U.S. manufacturer, London International, could potentially outsell Japanese ultra-thin condoms. The polyurethane products can be made at a uniform thinness, resulting in a more sensitive condom. Industry analysts are not sure about the impact of a plastic condom. Some feel that even if they prove to be safer than latex condoms, polyurethane condoms will have a difficult time competing against established brands. Others feel that if consumer response is positive, the potential profits provide a strong incentive for companies to invest in the efficacy studies and marketing of a polyurethane product.
Keywords: Condoms/*SUPPLY & DISTRIBUTION/STANDARDS Human Japan Latex Male Polyurethanes United States NEWSLETTER ARTICLEKWDcondoms/KWDsupply&distribution/standardshumanjapanlatexmalepolyurethanesunitedstatesnewsletterarticle
950430
M9541101

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .